Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guohua Yu

Showing results (181-190 of 235) with videos related to

Pageof 24
Sort By:
Molecular Reproduction and Development|October 28, 2008
Generation of goats lacking prion proteinGuohua Yu, Jianquan Chen, Yuanyuan Xu, et al.
Frontiers in Immunology|November 7, 2025
Case Report: Challenges in immunotherapy for the elderly: a case of refractory ICI-induced AIHA and thrombocytopenia in advanced gastric cancerMingxin Yu, Yanhong Ding, Linlin Ji, et al.
Experimental Neurology|May 10, 2015
In vivo protein targets for increased quinoprotein adduct formation in aged substantia nigraGuohua Yu, Huiyan Liu, Wei Zhou, et al.
Meta Gene|January 22, 2015
Current evidence on the four polymorphisms of VDR and breast cancer risk in Caucasian womenBaohong Yang, Shuzhen Liu, Xueling Yang, et al.
Oncology Letters|July 10, 2024
Real‑world evidence of advanced non‑small cell lung carcinoma treated with an immune checkpoint inhibitor plus chemotherapyZihan Xu, Huien Zhang, Guikai Ma, et al.
European Journal of Cancer (Oxford, England : 1990)|September 24, 2025
Efficacy and safety of MRG002 monotherapy in treating patients with locally advanced or metastatic breast cancer with low HER2 expression: A multi-center, non-randomized, open-label phase II clinical trialShaohua Zhang, Tao Sun, Xiaojia Wang, et al.
Hematological Oncology|April 28, 2022
Targeting MYC and BCL2 by a natural compound for "double-hit" lymphomaXiaoqian Liu, Senlin Xu, Jiawei Zhang, et al.
British Journal of Haematology|May 4, 2021
A novel MYC-non-IG fusion in refractory diffuse large B-cell lymphomaCheng Wang, Pamela A Althof, Chengfeng Bi, et al.
Infection and Drug Resistance|May 27, 2021
Cost Effectiveness of Different Initial Antimicrobial Regimens for Elderly Community-Acquired Pneumonia Patients in General WardXiudi Han, Liang Chen, Yimin Wang, et al.
Cell Death & Disease|June 16, 2025
Repurposing MDM2 inhibitor RG7388 for TP53-mutant NSCLC: a p53-independent pyroptotic mechanism via ROS/p-p38/NOXA/caspase-3/GSDME axisGaoyan Tang, Xuelei Cao, Jiaqi Chen, et al.
Pageof 24

Showing results (181-190 of 235) with videos related to

Sort By:
Pageof 24
Molecular Reproduction and Development|October 28, 2008
Generation of goats lacking prion proteinGuohua Yu, Jianquan Chen, Yuanyuan Xu, et al.
Frontiers in Immunology|November 7, 2025
Case Report: Challenges in immunotherapy for the elderly: a case of refractory ICI-induced AIHA and thrombocytopenia in advanced gastric cancerMingxin Yu, Yanhong Ding, Linlin Ji, et al.
Experimental Neurology|May 10, 2015
In vivo protein targets for increased quinoprotein adduct formation in aged substantia nigraGuohua Yu, Huiyan Liu, Wei Zhou, et al.
Meta Gene|January 22, 2015
Current evidence on the four polymorphisms of VDR and breast cancer risk in Caucasian womenBaohong Yang, Shuzhen Liu, Xueling Yang, et al.
Oncology Letters|July 10, 2024
Real‑world evidence of advanced non‑small cell lung carcinoma treated with an immune checkpoint inhibitor plus chemotherapyZihan Xu, Huien Zhang, Guikai Ma, et al.
European Journal of Cancer (Oxford, England : 1990)|September 24, 2025
Efficacy and safety of MRG002 monotherapy in treating patients with locally advanced or metastatic breast cancer with low HER2 expression: A multi-center, non-randomized, open-label phase II clinical trialShaohua Zhang, Tao Sun, Xiaojia Wang, et al.
Hematological Oncology|April 28, 2022
Targeting MYC and BCL2 by a natural compound for "double-hit" lymphomaXiaoqian Liu, Senlin Xu, Jiawei Zhang, et al.
British Journal of Haematology|May 4, 2021
A novel MYC-non-IG fusion in refractory diffuse large B-cell lymphomaCheng Wang, Pamela A Althof, Chengfeng Bi, et al.
Infection and Drug Resistance|May 27, 2021
Cost Effectiveness of Different Initial Antimicrobial Regimens for Elderly Community-Acquired Pneumonia Patients in General WardXiudi Han, Liang Chen, Yimin Wang, et al.
Cell Death & Disease|June 16, 2025
Repurposing MDM2 inhibitor RG7388 for TP53-mutant NSCLC: a p53-independent pyroptotic mechanism via ROS/p-p38/NOXA/caspase-3/GSDME axisGaoyan Tang, Xuelei Cao, Jiaqi Chen, et al.
Pageof 24